a stock that's not growing won't get a 14-15x EBITDA multiple.
might not even get a 14-15x P/E multiple.
thats the problem with this revision.
- Forums
- ASX - By Stock
- KGN
- Ann: May 2021 Business Update
Ann: May 2021 Business Update, page-57
-
-
- There are more pages in this discussion • 101 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KGN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.49 |
Change
0.040(0.90%) |
Mkt cap ! $451.7M |
Open | High | Low | Value | Volume |
$4.46 | $4.58 | $4.41 | $1.987M | 440.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 9735 | $4.48 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.50 | 7437 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 7657 | 4.480 |
8 | 4879 | 4.470 |
14 | 13553 | 4.460 |
13 | 11902 | 4.450 |
12 | 19933 | 4.440 |
Price($) | Vol. | No. |
---|---|---|
4.490 | 1665 | 11 |
4.500 | 7305 | 16 |
4.510 | 29405 | 19 |
4.520 | 5741 | 10 |
4.530 | 11462 | 11 |
Last trade - 14.34pm 15/07/2024 (20 minute delay) ? |
Featured News
KGN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online